Iqvia named short-term buy idea at Deutsche Bank

Deutsche Bank placed a "Catalyst call: Buy" on shares of Iqvia as a short-term investment idea. Iqvia has traded down 10% year-to-date and has underperformed peers despite 2026 guidance that the firm calls "in line-to-better than buy-side expectations" amid what it believes are "misplaced fears" related to the company's business mix and the threat of AI / ML to industry profit pools. Recent industry checks and favorable macro trends proof points of the cyclical recovery in end-market demand, the analyst tells investors. The firm has a Buy rating and $240 price target on shares.